Se rendre au contenu

SARS-CoV Spike Glycoprotein Stable Cell Line

https://www.seniorscientific.com/web/image/product.template/34538/image_1920?unique=3e65c96
(0 avis)
SARS-CoV Spike Glycoprotein Cell Line has been developed by stably transfecting HEK293T cell line with a SARS-CoV Spike Glycoprotein expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV Spike Glycoprotein in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV Spike Glycoprotein with hygromycin resistance gene. SARS-CoV Spike Glycoprotein Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV Spike Glycoprotein HEK293T Cell line also allow to establish in vitro models for High Throughput and High Content Screening. Severe acute respiratory syndrome coronavirus (SARS-CoVs) infect human and animals and cause varieties of diseases, such as respiratory, enteric, renal, and neurological diseases. SARS-CoV uses its spike glycoprotein (S), a main target for neutralization antibody, to bind its receptor, and mediate membrane fusion and virus entry. It uses hACE2 to enter cells, correlating with the efficient spread of SARS-CoV among humans. S comprises two functional subunits responsible for binding to the host cell receptor (S1 subunit) and also fusion of the viral and cellular membranes (S2 subunit). SARS-CoV Spike Glycoprotein Cell Line cell line allows the study of SARS-CoV spike/ACE2 interaction in cell-based assays.

123 456,00 123456.0 USD 123 456,00

123 456,00

Not Available For Sale

Cette combinaison n'existe pas.

20 tests available in this pack 

Conditions générales
Garantie satisfait ou remboursé de 30 jours
Expédition : 2-3 jours ouvrables


Référence interne: AS-IMMUNE-113
URL de site web: /shop/as-immune-113-sars-cov-spike-glycoprotein-stable-cell-line-34538